| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained |
| 02/18/1999 | WO1999007871A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | WO1999007868A1 Immunologically privileged cells and uses thereof |
| 02/18/1999 | WO1999007860A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | WO1999007827A1 Use of lactobacillus for reduction of the fibrinogen level in blood |
| 02/18/1999 | WO1999007826A1 Novel lactic acid bacteria |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007396A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | WO1999007394A1 Use of herpes vectors for tumor therapy |
| 02/18/1999 | WO1999007393A1 Pharmaceutical product comprising bacterial strains for the colon therapy |
| 02/18/1999 | WO1999007392A1 Isoflavone-containing compositions |
| 02/18/1999 | WO1999007391A1 Ratite extracts as therapeutic agents |
| 02/18/1999 | WO1999007390A1 A universally applicable blood plasma |
| 02/18/1999 | WO1999007332A2 A natural eubiotic product for maintenance and treatment of teguments |
| 02/18/1999 | WO1999007208A1 Hypersensitive response elicitor from erwinia amylovora and its use |
| 02/18/1999 | WO1999007206A1 Hypersensitive response elicitor from erwinia amylovora, its use, and encoding gene |
| 02/18/1999 | WO1998051353A3 Artificial bodily fluid |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | CA2301198A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2300193A1 Hypersensitive response elicitor from erwinia amylovora, its use, and encoding gene |
| 02/18/1999 | CA2299627A1 Novel lactic acid bacteria |
| 02/18/1999 | CA2299565A1 Hypersensitive response elicitor from erwinia amylovora and its use |
| 02/18/1999 | CA2298840A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | CA2298679A1 Isoflavone-containing compositions |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896824A1 A universally applicable blood plasma |
| 02/17/1999 | EP0896542A1 Method of restoring a functional protein in a tissue by cell transplantation |
| 02/17/1999 | EP0896506A1 Methods for inducing immune responsiveness in a subject |
| 02/17/1999 | CN1207944A Rheumatism capsule |
| 02/17/1999 | CN1207941A Anti-senility medicine and its preparation |
| 02/17/1999 | CN1207940A Anticancer medicine and its preparation |
| 02/17/1999 | CN1207931A Hyperosteogeny plaster |
| 02/17/1999 | CN1207926A Gastrosis plaster |
| 02/17/1999 | CN1207925A Blood pressure depressing Yongquan plaster |
| 02/17/1999 | CN1207921A Quick acting Chinese medicine for various headaches and its preparation |
| 02/17/1999 | CN1207909A Oral liquid for curing cancer |
| 02/17/1999 | CN1207905A Weichangning powder for curing gastroenteritic diseases |
| 02/17/1999 | CN1207901A External-use Chinese medicine |
| 02/17/1999 | CN1207900A Protease hydrolyzed pearl solution producing process |
| 02/17/1999 | CN1207899A Shengbai Opsonin as one biological preparation for preventing and curing leucocytopenia caused by chemotherapy |
| 02/16/1999 | US5872227 Aggregation of cell membranes by lowering ph and separation of components |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872154 Method of reducing an immune response to a recombinant adenovirus |
| 02/16/1999 | US5872095 IL-1 receptor antagonists medicaments |
| 02/16/1999 | US5871997 A gene therapy treating with a glycolytic enzyme |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871985 Vehicles containing cells for implanting in the tissue of an individual are prepared having cells dispersed in a particulate, essentially non cross-linked chitosan core matrix that is enclosed within a semipermeable membrane |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871728 Enhancing tolerogenicity in host mammal to transplant graft specimen from donor; propagation in cytokine prior to administering |
| 02/16/1999 | US5871726 Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen |
| 02/16/1999 | US5871725 In the absence of alone or in combination with interleukin-two; anticarcinogenic agents |
| 02/16/1999 | US5871472 To preselected brain areas |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
| 02/11/1999 | WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006441A1 Proteinic product, process for its preparation, compositions containing it and use in medicaments |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | DE19828596A1 Use of polyvalent bacteriophages |
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
| 02/11/1999 | CA2298061A1 Polynucleotide compositions |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2244801A1 Suppressory agents against hypercoagulation |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0895534A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 02/10/1999 | EP0895476A1 Treatment of non-neuronal cancer using hsv mutant |
| 02/10/1999 | EP0693120B1 Tumoricide t lymphocytes |
| 02/10/1999 | CN1207771A Methods and compositions for diagnosis and treatment of cancer |
| 02/10/1999 | CN1207682A Method and material for hair therapy |
| 02/10/1999 | CN1207416A Ecological balance nutrient 'Jinghuosu' and its producing method |
| 02/10/1999 | CN1207411A Health tincture of three-animal penises and preparing process thereof |
| 02/10/1999 | CN1207321A Oral liquid for treating tumor |
| 02/10/1999 | CN1207320A Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof |
| 02/10/1999 | CN1207319A Medicine for treating osteoproliferation, rheumatism and rheumatoid arthritis, and preparing method thereof |
| 02/10/1999 | CN1207318A Ointment for treating burn and scald |
| 02/10/1999 | CN1207316A Pile eliminating powder |
| 02/10/1999 | CN1207315A 'Binuting' medicine for treating hemorrhinia |
| 02/10/1999 | CN1207308A Juice for tonifying kidney and nourishing stomach |
| 02/10/1999 | CN1207303A Chinese medicine preparation for treating prospermia and preventing impotence |
| 02/10/1999 | CN1207300A Medicine for giving up drug |
| 02/10/1999 | CN1207297A Process for producing royal jelly freeze-dried powder |
| 02/10/1999 | CN1207296A Method for preparing pantocrine injection |
| 02/10/1999 | CN1041992C Preparation process of common cold resistant panacea tablet |
| 02/09/1999 | US5869701 Method of inactivation of viral and bacterial blood contaminants |
| 02/09/1999 | US5869645 Extracting glycans from mycobacteria using aqueous solution |
| 02/09/1999 | US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines |
| 02/09/1999 | US5869615 Analog proteins involved in alternative pathways of the immune system; therapuetic treatments of complement mediated disorders: autoimmune disease, suppress transplant rejections, aids in reduction of tissue damage |
| 02/09/1999 | US5869537 Macrophage lipid chemoattractant |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |